Digital Future-Proofing Health Systems: Insights from Frontiers Heal... At Frontiers Health 2025, we caught up with Moredreck Chibi (World Health Organization) and Chrys Herrera (Merck KGaA).
News Kyverna rises on stiff person syndrome data Kyverna hopes to file CAR-T therapy miv-cell for approval as the first therapy for stiff person syndrome, a rare and debilitating autoimmune disease.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.